The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Prismasol 2 mmol/l Potassium solution for haemodialysis/haemofiltration



Baxter Holding B.V.PA2299/052/002

Main Information

Trade NamePrismasol 2 mmol/l Potassium solution for haemodialysis/haemofiltration
Active SubstancesGlucose (as monohydrate)
Magnesium chloride hexahydrate
Calcium chloride dihydrate
Lactic acid
Sodium chloride
Potassium chloride
Sodium hydrogen carbonate
Calcium
Magnesium
Sodium
Chloride
Lactate
Hydrogen carbonate
Potassium
Glucose
Dosage FormSolution for haemodialysis/haemofiltration
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/052/002

Group Information

ATC CodeB05ZB Hemofiltrates

Status

License statusAuthorised
Licence Issued05/10/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back